BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Dec 31, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-12-29

Reporting Person: Babu Yarlagadda S (Senior VP - Drug Discovery)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-29	Emp. Stock Option (Right to Buy)	$10.82	A	62573	Acquired	2025-12-29	Common Stock (62573)	Direct

Footnotes

F1: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.